Lyrus logo

Lyrus

Lyrus is a research and development (R&D) organisation doing contract drug development & manufacturing #CDMO

112 employees · est. 2015 · India

VS
Slayback Pharma logo

Slayback Pharma

Slayback Pharma believe every pharmaceutical product exhibits its own unique personality

41 employees · est. 2011 · Princeton, United States

Slayback Pharma is the older company (2015 vs 2011); Lyrus is the larger of the two.

Side-by-Side Comparison

Lyrus Slayback Pharma
Founded
2015 2011 older
Headquarters
India Princeton, United States
Employees
112 larger 41
Industry
Life Sciences, Manufacturing, Pharmaceutical Biopharma, Manufacturing, Pharmaceutical
Funding Stage
Not tracked yet Acquired
Total Funding
Not tracked yet $110.00M
Funding Rounds
Not tracked yet 3
Services
Not tracked yet Development of Pharmaceuticals, Marketing and Sales, Patient Direct Solutions, Patient Support Programs, Educational Grant Applications
Target Customers
Not tracked yet Overlooked Patients, Patients with Chronic Diseases, Healthcare Providers, Pharmacists
Taxonomy
Contract Drug Development, Pharmaceutical Manufacturing, Research & Development, Diagnostics, Immunology, Drug Delivery Systems, Nutraceuticals, OTC Products, Innovation, Generic Medicines, Biosimilars Complex Generics, Specialty Pharmaceuticals, Complex Injectables, Non-Solid Oral Products, Drug Delivery Technologies, Contract R&D, Manufacturing Network, Sterile Formulations, Nano-spheres, Oil-in-Water Emulsions, Hormonal Products, Cross-Contamination Control, Cost-Reduction In Therapy, Value Proposition Development, Innovative Drug Development
Website
lyruslife.com slayback-pharma.com
Lyrus logo

About Lyrus

Lyrus is an India-based research and development (R&D) organization specializing in contract drug development and manufacturing (CDMO). With a focus on creating innovative pharmaceutical products, Lyrus aims to enhance the quality of life for individuals. The company's leadership team boasts over 30...

Slayback Pharma logo

About Slayback Pharma

Slayback Pharma, founded in 2011, is a specialty pharmaceutical company based in the United States. They focus on developing and manufacturing complex generic pharmaceutical products, placing significant emphasis on complex injectables and non-solid oral products. Their portfolio stands out through...

We will tell you when either one moves

BounceWatch watches Lyrus and Slayback Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lyrus and Slayback Pharma — by email.

Frequently Asked Questions

Lyrus — Lyrus is a research and development (R&D) organisation doing contract drug development & manufacturing #CDMO . Slayback Pharma — Slayback Pharma believe every pharmaceutical product exhibits its own unique personality. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lyrus has raised undisclosed funding while Slayback Pharma has raised $110.00M.
Lyrus and Slayback Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lyrus with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Lyrus on 14 Sep 2024, and Slayback Pharma on 10 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy